Fankai Meng
0000-0002-6838-3955
Publication & Citation Trends
Most Cited Works
Publications
117 total
Expert Consensus on Cytomegalovirus Management in Recipients of CAR‐T Cell and Bispecific Antibody Therapies
Cited by 0
Semantic Scholar
Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma
Cited by 0
Semantic Scholar
Comparative Analysis of T‐Cell and Bone Marrow Chimerism for Relapse Prediction in Acute Leukaemia Post‐Transplantation
Cited by 0
Semantic Scholar
Long-term therapy outcomes of CD19/22 CAR T-cell alone or with autologous stem cell transplantation for relapsed/refractory DLBCL.
Cited by 0
Semantic Scholar
Development of a Diagnostic Algorithm for Epstein‐Barr Virus‐Related Diseases: A Retrospective Observational Study
Cited by 2
Semantic Scholar
Efficacy and safety of zanubrutinib combined with chimeric antigen receptor T-cell therapy targeting CD19 in refractory or relapsed diffuse large B cell lymphoma: A retrospective analysis.
Cited by 3
Semantic Scholar
Comparison of haploidentical-hematopoietic stem cell transplantation using modified post-transplantation cyclophosphamide and eltrombopag combined with immunosuppression for the treatment of severe aplastic anemia.
Cited by 0
Semantic Scholar
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD.
Cited by 6
Semantic Scholar
Research Topics
CAR-T cell therapy research
(26)
Hematopoietic Stem Cell Transplantation
(19)
Acute Myeloid Leukemia Research
(16)
Lymphoma Diagnosis and Treatment
(14)
Chronic Lymphocytic Leukemia Research
(10)
Frequent Co-Authors
Affiliations
Jilin University
People 's Hospital of Jilin Province
Hubei Provincial Center for Disease Control and Prevention
Second Hospital of Shandong University
First Hospital of Jilin University